Skip to main content
Clinical Trials/IRCT20231226060526N1
IRCT20231226060526N1
Recruiting
Phase 3

Investigating the effect of dexamethasone injection in the first 24 hours in preventing kidney scaring in children with pyelonephritis

Sanandaj University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute pyelonephritis.
Sponsor
Sanandaj University of Medical Sciences
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sanandaj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Children from 1 month to 12 years with first episode of fever T \> 38°C
  • having a urinary tract infection and a positive urine culture
  • The presence of a positive urine culture, which according to the definition includes at least 100000 CFUs/mL from a clean sample obtained with a urine bag, or at least 10000 CFUs/mL from a sample obtained by catheterization, or the growth of any amount of bacteria from a sample obtained by suprapubic aspiration.

Exclusion Criteria

  • Endocrine disease
  • Immunosuppressive therapy
  • Known cancer or uropathy
  • Those who had an abnormal DMSA before late assessment (at least 6 months follow\-up) had a second UTI.

Outcomes

Primary Outcomes

Not specified

Similar Trials